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1. INTRODUCTION 
Nootropics, popularly referred to as "smart drugs," are 
substances which boost human cognitive abilities (the 
functions and capacities of the brain. The word nootropic 
is derived from the Greek words noos or mind and tropos, 
a growth. Typically, nootropics work by increasing the 
brain's supply of neurochemicals (neurotransmitters, 
enzymes, and hormones), by improving the brain's oxygen 
supply, or by stimulating nerve growth. With a few notable 
exceptions, nootropics have very low or no toxicity, 
making overdose unlikely. 
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Most nootropics are nutrients 
or plant components (herbs, roots, beans, bark, etc.), 
available over the counter at health food and grocery 
stores, and are used as nutritional supplements. Some 
nootropics are drugs, used to treat retardation, neural 
degradation (Alzheimer's and Parkinson's), and for cases of 
oxygen deficit to prevent hypoxia. These drugs have a 
variety of human enhancement applications as well, are 
marketed heavily on the World Wide Web, and are used by 
many people in personal cognitive enhancement regimens. 
With some nootropics the effects are subtle and gradual, 
such as with most nerve growth inducers, and may take 
weeks or even months before any cognitive improvement 
is noticed. At the other end of the spectrum are nootropics 
which have effects that are immediate, profound, and 
obvious.
20 
2. EPIDIMIOLOGY: 
Mental function often declines particularly under 
conditions of stress or fatigue. In addition, most people 
over the age of 40 experience some memory loss, 
technically known as Age-related Cognitive Decline 
(ARCD) or Age-associated Memory Impairment (AAMI). 
We don't know what causes this normal experience, and 
there is no conventional treatment available for it certain 
conditions can cause a far more serious loss of mental 
function.
7,8
 
3. CLASSIFICATION 
7-10
 
First-generation compounds  
 Psychostimulants: 
The psychostimulants reinforce behavioural activities 
and, in all likelihood, act as thymoleptics or as 
activators of attention-inducing processes. Eg. 
Caffiene,  Nicotinnic acid. 
 Metabolic compounds: 
It has been suggested that the so-called nootropic 
compounds, which act as neither stimulants nor 
sedatives, are likely to improve learning and 
memory. Such compounds are typically activators of 
cerebral metabolism. eg.  Vinpocetine. 
 Cerebro vascular compounds 
These drugs have been used to improve cerebral blood 
flow and bioavailability of oxygen on an explanatory 
basis; this approach was subsequently shown to be flawed, 
since cerebral atherosclerosis was shown to be the initial 
causative pathophysiological anomaly in senile dementia. 
Eg. Ginkgo biloba, Vinpocetine  
Second-generation compounds  
 Cholinergic drugs: 
The "cholinergic hypothesis" of age-related memory 
dysfunction has resulted in the clinical evaluation of three 
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types of cholinomimetics: acetylcholine (ACH) precursors, 
acetylcholinesterase (AChE) inhibitors and cholinergic 
receptor agonists. The use of choline (precursor of the 
synthesis of ACH) or of lecithin (the food source of 
choline) is warranted Their potential ability to increase the 
bioavailability of ACH in presynaptic egions. Recently, 
new, more selective muscarinic receptor agonists have 
been studied, particularly substances that stimulate the 
nicotinic cholinergic receptors. The discovery both in vitro 
and in animal models of stimulation of cholinergic 
receptors supports the notion of cell trophism, and opens 
up interesting new horizons in clinical practice in the vast 
domain of nerve-cell protection. This also applies to 
nicotinic receptors, nicotine and nicotinic agonists such as 
ABT-418 which exert a beneficial effect on mood, 
vigilance and memory although there is nevertheless a risk 
of addiction. eg. Huperzine-A, Vitamin B-5 (Huperzine-A 
is a potent Ach esterase inhibitor and Vit. B-5 is a cofactor 
in the conversion Choline in to neurotransmitter.) 
 Substances acting on neurotransmissionsystem: 
Disturbance of other neurotransmitter systems involved in 
learning and memory (noradrenaline, serotonin and 
probably dopamine) also occurs in AD). The 
improvements noted in cognitive function could be 
secondary to beneficial effects on attention, vigilance or 
psychomotor functions. This also applies to substances 
such as monoamine oxidase type-A (MAO-A) inhibitors. 
A subtype of glutamate receptor, the N-methyl-D-aspartate 
(NMDA) receptor, plays a key role in long-term 
potentiation (LTP), an elementary model of cellular 
memory . Substances designed to heighten the activity of 
NMDA receptors are currently under development. This 
mechanism is generally an indirect result of modulation of 
the receptor itself. eg.Vit.B-6, Vit-C, Yohimbe 
(Dopaminergics), theanine     
 Neuropeptides: 
The neuropeptides modify behaviour by their action within 
the central nervous system, either as true 
neurotransmitters, or as modulators of known 
neurotransmitters. Neuropeptides such as 
adrenocorticotropic hormone (ACTH) analogues and 
vasopressin have been shown to exert beneficial effects on 
learning and memory in animal models. Although 
analogues of ACTH (ACTH 4-10 and ACTH 4-9) improve 
attention, concentration and motivation in healthy young 
volunteers, no benefits have been shown either in normal 
elderly subjects or in AD patients. Similarly, vasopressin-
type peptides induce non-specific central stimulation rather 
than direct improvement of memory in AD. Somatostatin, 
corticotrophin-releasing factor (CRF), neuropeptide Y and 
other neuropeptides are unquestionably decreased in the 
brain of AD patients, but unfortunately, for the moment, 
all therapeutic strategies based on supplements of these 
substances and all pharmaceutics research are faced with 
difficult technical problems. 
Third-generation compounds  
 Neurotrophic factors: 
One of the most promising and interesting fields of 
research in neuroscience involves the use of growth 
factors, in particular Nerve Growth Factor (NGF), to 
reinforce the viability of neurones. Since a number of 
changes in the central nervous system related to 
physiological age or dementia are associated with loss of 
neurones, the use of growth factors to prevent or delay cell 
death could have a considerable impact on the preservation 
of memory and other cognitive functions. In animal 
models, NGF increases the viability and survival of 
cholinergic nuclei in the brain stem, as well as improving 
learning and memory in animals with experimentally 
induced lesions in this region. NGF crosses the blood-brain 
barrier only with difficulty and requires administration 
either by the intraventricular route or in combination with 
a carrier molecule (transporter).; novel compounds arising 
from chemical synthesis possess true neurotrophic 
properties and are currently undergoing clinical evaluation 
as potential neurocytoprotectants (certain MAO-B 
inhibitors, SR57746, etc.). 
 Abnormal proteins: 
Certain familial forms of AD involve excessive production 
of amyloid peptides. Amyloid accumulation is at the heart 
of senile plaques, the histopathological stigmata of AD. 
Research is currently being undertaken to produce methods 
of suppressing this abnormal overproduction, attempting 
for example to act upon the metabolic processes 
(secretases) resulting in the amyloid protein precursor 
(APP), or on recently-identified amyloid receptors. 
Variations in the apolipoprotein E gene (APOE) on 
chromosome 19 may constitute a risk factor for AD.  
Fourth –generation compounds 
The considerable increase in knowledge concerning the 
pathogenesis and origin of memory disorders in elderly 
subjects and in dementia, including AD, as well as the 
introduction of innovative therapies including 
biotechnology and molecular gene therapies, constitute the 
basis of effective treatments and preventive measures for 
disturbances of the central nervous system responsible for 
this cognitive dysfunction. Methods involving regulation 
of synthesis of abnormal proteins could hasten the 
development of fourth-generation medications.
 
4. GENERAL MECHANISM OF ACTION 
4.1 General strategies: 
Neurotransmitter support - supplying the body with the 
precursors and cofactors it needs to produce 
neurotransmitters. Keeping the brain's neurotransmitters at 
high levels improves concentration, mental focus, 
calculation ability, memory encoding, recall, 
neurotransmitters are acetylcholine, dopamine, 
norepinephrine and serotonin. Note that cardiovascular 
exercise performed on a regular basis also has nootropic 
effects, by increasing the body's capacity to supply brain 
cells with oxygen. Exercise is highly synergistic with 
nutritional supplementation, and a health regimen is 
incomplete without it. 
4.2 Replenishing and increasing neurotransmitters: 
Thinking is hard workIt involves the firing of neurons 
which requires plenty of neurotransmitters, and even 
though these are reuseable to some extent, they do get 
depleted. Depletion of neurotransmitters generally results 
in reduced mental performance, which may include 
difficulty concentrating, slowed reasoning, decreased 
learning efficiency, impaired recall, reduced coordination, 
lowered moods, inability to cope, increased response 
times, and mental fatigue. This also generally increases the 
likelihood of human error on tasks and activities 
Kapoor et al                                      Journal of Drug Delivery & Therapeutics; 2013, 3(5), 163-171    165 
© 2011, JDDT. All Rights Reserved                                                       ISSN: 2250-1177                                                      CODEN (USA): JDDTAO 
performed. Stress causes neurotransmitters to be depleted 
even faster. The brain's neurotransmitters need to be 
replenished frequently, made by the body from substances 
ingested in the diet. Maintaining neurochemicals at 
optimal levels has a corresponding effect on brain 
performance supporting improved mental agility and 
stamina, even beyond the individual's normal limits. As the 
brain ages, its ability to produce and maintain youthful 
levels of neurotransmitters declines providing the brain 
with ample raw materials to make the neurotransmitters it 
needs can restore them to more youthful levels to help 
maintain cognitive function at vigorous youthful levels as 
well.
21 
 
 
Figure 1: Pathway of action of nutrients on memory molecule acetylcholine 
4.3 Recreational drugs with purported nootropic 
effects: 
LSD - Schedule I / Class A drug. At minuscule doses (1 
mcg) the drug has effects similar toHydergine. Overdose 
and side-effects: produces inebriating hallucinogenic and 
entheogenic effects at doses as low as 20–30 μg 
(micrograms), with the likelihood of having a bad trip 
increasing as dose is increased. May also cause cognitive 
shifts, synesthesia, and flashbacks. The drug sometimes 
spurs long-term or even permanent changes in a user's 
personality and life perspective, can cause Hallucinogen 
Persisting Perception Disorder, and post-LSD psychoses 4-
methylaminorex.
25 
4.4 Anti-depression, adaptogenic and mood 
stabilization: 
Depression and depressed mood negatively affect 
cognitive performance, Feelings of sadness, guilt, 
helplessness, hopelessness, anxiety, and fear caused by 
depression detract from productive thought while apathy 
(which is also induced by depression) is the lack of 
motivation and driving moods (like curiosity, interest, 
determination, etc.) Other symptoms include disturbed 
sleep patterns, mental fatigue and loss of energy, trouble 
concentrating or making decisions, and a generalized 
slowing and obtunding of cognition, including memory 
Obviously, removing these effects improves intelligence 
and mental performance and therefore, counteracting and 
preventing depression are effective nootropic strategies. 
There is a high correlation between depression and a 
reduction or depletion of neurotransmitters (dopamine, 
acetylcholine, and serotonin) in the brain therefore it is no 
surprise that increasing the brain's supply of 
neurotransmitters alleviates (or at least reduces the 
symptoms of) most depressions Stress is another major 
factor in neurotransmitter depletion, being both a cause 
and effect of it (creating a vicious downward cycle) 
therefore stress management and anti-stress substances are 
also very useful nootropic strategies.
24
All of the "nergics" 
listed above have been found to increase stress tolerance 
and alleviate depression (by replenishing or increasing the 
brain's supply of specific neurotransmitters), especially 
when used in precursor/co-factor combinations. Here are 
some more nootropics which affect mood and stress: 
 Ashwagandha (Withania somnifera) - Root. Also 
known as Indian ginseng. Adaptogen used as a tonic 
to normalize body processes and reduce stress and 
anxiety.
19
 
 Inositol- is a B-vitamin like substance with anti-
anxiety effects. It is believed to produce its anti-
anxiety effects by improving the binding of gabaergics 
to GABAA receptors Inositol is a sugar, and is 
therefore an alternative energy source for brain and 
muscle tissues. It produces a sugar high without a 
sugar low, making it especially suited for sweetening 
tea (instead of sugar). It is also a membrane stabilizer 
which can strengthen neurons.
22
 
 Lemon balm (Melissa officinalis) – herb. Anti-
depressant
21
 
 Rhodiola rosea- herb. Adaptogen; elevates mood 
alleviates depression promotes mental energy and 
stamina reduces fatigue. 
 St John's wort - herb. The active components: 
hypericin and hyperforin, are clinically indicated to be 
effective in cases of mild to medium depression. 
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 Ginseng, Siberian (Eleutherococcus senticosus) - root. 
Anti-anxiety adaptogen that normalizes physical stress 
and mental consequences.
19
 
 Sutherlandia Frutescens – herb. Adaptogen, blood 
detoxifier 
 Tea – herb contains theophylline and theanine. 
Increases alpha-wave based alert relaxation (relieves 
stress).
19
 
 Theanine - amino acid. Found in tea. Increases 
serotonin and dopamine levels in the brain. Increases 
alpha- wave based alert relaxation. 
 Vasopressin - drug. Memory hormone, produced by 
the pituitary gland, improves both memory encoding 
and recall rapidly counters chronic apathy syndrome 
and drug-induced depletion. 
 Nicotinic acid (vitamin B3) - essential nutrient. Mild 
enhancer of concentration and memory vasodilator 
mood stabilizer, with a powerful anti-anxiety effect 
perhaps the best and most immediate stress reliever 
available (note that other forms of vitamin B3 do not 
have this effect.) 
Side effects: gastric upset (which is easily prevented and 
relieved with antacids), reduced blood pressure and 
flushing of the skin (caused by vasodilation) and itchy 
sensation in the skin caused by histamine release.         
4.5 Brain energy and improved oxygen supply: 
 Chromium stabilizes blood sugar levels promoting 
concentration 
 Coenzyme q-10- increases oxygen transport through 
the mitochondria of the cells. Appears to slow age 
related dementia. 
 Creatine increases brain energy levels via ATP 
production. 
4.6 Mental agility, Concentration, Stamina, And Focus: 
 Caffeine improves concentration, idea production, but 
hinders memory encoding. Also produces the jitters 
caffeine is the most widely used psychoactive 
substances in the world. 
 Coffee bean contains caffeine, brewed coffee is high 
in antioxidants 
 Nicotine stimulus barriers (aids in concentration) 
stimulus barrier rebound effect(an unpleasant side 
effect) 
4.7 Memory enhancement and learning improvement: 
All of the "nergics" listed above improve memory 
(encoding and recall) So do all nootropics which improve 
general brain performance such as the brain energy and 
oxygen suppliers listed above and the nerve growth 
stimulants and protectants listed in their own section 
below. Other nootropics with specific effects on memory 
encoding and recall include: 
 Bacopa monnieri (Brahmi) - Herb. Elevates curiosity, 
enhances memory and concentration 
 Vasopressin - Hormone, prescription drug24 
4.8 Nerve growth stimulation and brain cell protection: 
 Bacopa monnieri (Brahmi) - Herb. Improves protein 
synthesis in brain cell repair and new dendritic 
growth. 
1,19
Inositol - Membrane stabilizer. Strengthens 
neurons, making them less susceptible to damage.
21
 
 Vitamin C - Membrane stabilizer, involved in collagen 
synthesis. Strengthens neurons {{fact}, making them 
less susceptible to damage {{fact}. Vitamin C is also a 
co-factor in the brain's production of dopamine, and 
therefore it also has general nootropic effects.
3
 
4.9 Sleep enhancement or reduction: 
 Modafinil (Provigil) - drug. Major sleep reducer, 
reduces symptoms of sleep deprivation, reduces 
sleepiness, improves concentration, increases mental 
stamina, and reduces ADD/ADHD. Produces 
relatively few side-effects, with no catch-up sleep 
required Has been reported to extend the period of 
normal wakefulness to 90 hours, without feelings of 
weirdness or the "jitters". Long term effects on health 
are unknown. 
 Vitamin B12 - can greatly enhance the color of 
dreams. Stimulates brain neuron RNA synthesis.
3
 
4.10 Recreational drugs with purported nootropic 
effects: 
 LSD - Schedule I / Class A drug. At minuscule doses 
(1 mcg) the drug has effects similar to Hydergine. 
Overdose and side-effects: produces inebriating 
hallucinogenic and entheogenic effects at doses as low 
as 20–30 μg (micrograms), with the likelihood of 
having a bad trip increasing as dose is increased. May 
also cause cognitive shifts, synesthesia, and 
flashbacks. The drug sometimes spurs long-term or 
even permanent changes in a user's personality and 
life perspective, can cause Hallucinogen Persisting 
Perception Disorder, and post-LSD psychoses. 4-
methylaminorex.
25
 
5. STAGES IN PRODUCTION OF MEMORY 
RELATED SYNAPTIC CHANGES: 
The Production of stable synaptic changes is typically 
divided into induction, expression and consolidation 
phases. These relate to steps in memory formation 
introduced into the psychological literature with the 
discovery that electroconvulsive shocks applied shortly 
after learning erase memory. Subsequent decades of work 
confirmed that memory encoding involves two distinct 
steps: an acquisition process requiring a few seconds, 
followed by a series of changes that consolidate the new 
information against disruption and decay, which requires 
hours or even days. The manifestation of memory in 
behavior (such as recognition) constitutes a third 
component emerging immediately after acquisition and in 
advance of consolidation. LTP, as summarized below, 
seems to pass through a similar sequence of stages, two of 
which are logical target for mechanism-based memory 
drugs.
12 
The consensus induction model involves the two classes of 
transmitter receptors co-localized at excitatory 
(glutamatergic) synapses. AMPA-type glutamate receptors 
generate depolarization needed to unblock voltage 
sensitive NMDA-type glutamate receptors, which then 
admit calcium into the dendritic side of the synapse.
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Figure 2: Targets for the development of memory-enhancing drugs 
The production of memory-related synaptic changes 
occurs in three stages
12
.
 
Step 1: induction. Released transmitter binds to AMPA-
type glutamate receptors, which then depolarize the 
postsynaptic region and unblock NMDA-type receptors.  
Step 2: expression. NMDA receptors admit calcium and 
thereby modify AMPA receptors so as to increase the size 
of subsequent excitatory currents.  
Step 3: consolidation. NMDA receptors also trigger 
changes that stabilize the modifications to the AMPA 
receptors. A rapidly developing aspect of this (3A) 
involves adhesion receptors, whereas a more delayed 
component requires genomic events (3B). Current 
strategies for drug development (red asterisks) target the 
AMPA receptor component of induction or the gene-
signaling component of consolidation. 
Today most researchers hold that the enhanced 
postsynaptic currents that define LTP expression are 
caused by changes in AMPA receptors, but there is 
disagreement about how they are changed. Simply adding 
new receptors to the synaps would increase the response to 
a given amount of transmitter; one variant of this idea 
posits that recycling is co-opted so as to alter receptor 
number. The alternative is that extant receptors are 
modified so as to enhance their operation. The leading 
candidate for this process is serine phosphorylation of two 
sites on the 
cytoplasmic domain of the receptor. An important advance 
in consolidation came with the discovery that LTP is easily 
erased immediately after its induction but not after delays 
of 30-60 minutes. As with memory, the progressive 
resistance of LTP to disruption (consolidation) seems to 
have multiple phases. Adhesion proteins are implicated in 
steps beginning within minutes of induction, whereas 
protein synthesis is needed for phases occurring an hour or 
more later. 
The current search for memory drugs begins with the 
assumption that steps in memory formation correspond to 
steps in synaptic modification. This is not to argue that the 
behavioral phenomena can be reduced to plasticity: for 
example, the critical questions of memory organization 
and retrieval are barely addressed by current biological 
models. However, to the degree that initial encoding and 
later consolidation of memory depend upon the induction 
and stabilization of LTP,then drugs that enhance these 
cellular effects are expected to promote their behavioural 
reflections.
13
 
5.1 Drugs that facilitate induction: 
Repetitive release of transmitter over a period of 30−50 
milliseconds allows AMPA receptors to generate sufficient 
depolarization to unblock NMDA receptors and thereby 
induce LTP (Figure 2). Increasing the amount of glutamate 
released during stimulation or enhancing the effects of the 
transmitter on AMPA receptors can reduce this 
requirement. Work on the latter approach—positive 
modulation of AMPA receptors—is now well advanced 
and has resulted in competing families of drugs.
15 
Ampakines were the first allosteric modulators of AMPA 
receptors to augment excitatory transmission in brain. 
They have no detectable agonist or antagonist actions but 
instead modify two aspects of receptor biophysics—
desensitization and deactivation—that terminate the 
synaptic current. By slowing these two processes, 
ampakines enhance and prolong the synaptic currents 
generated by release of glutamate from axon terminals.
 
The drugs freely enter the brain, where they increase both 
glutamatergic transmission and the aggregate activity of 
cortical neurons controlling complex behaviors. As 
described in an extensive literature, these effects are 
accompanied by substantial improvements in retention 
scores on diverse tests that sample memories lasting for 
minutes, hours or weeks. Positive results are reported for 
tasks dependent upon different brain structures, types of 
rewards and training regimens. They also hold across 
species (rats, rabbits, monkeys). In all, positive modulation 
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of AMPA receptors reduces the requirements for the 
encoding of memory, whether the memory is of a type that 
normally persists for only a few minutes or instead 
normally lasts for an indefinite period.
14 
Being modulators, ampakines affect only those AMPA 
receptors activated by endogenously released transmitter 
and thus only those networks engaged by the brain's 
present activity. This feature, coupled with the absence of 
targets outside the central nervous system, presumably 
accounts for their positive effects on memory at dosages 
well below those that produce notable side-effects. 
(Seizures are the most severe risk factor.)
16
Additional 
modulators with chemical structures distinct from those of 
the ampakines have been discovered, beginning with the 
benzothiadiazides. Similar to the ampakines, one set of 
derivatives is reported to enhance excitatory transmission, 
promote the formation of LTP, and improve object 
recognition memory. Another series of 
biarylpropylsulfonamide variants is notable for its potency, 
with some members of the group being effective in the low 
nanomolar range. The diversity of these chemical 
structures points to the conclusion now supported with 
experimental evidence, that AMPA receptors have 
multiple modulatory sites. Linking chemical structures and 
modulatory sites with particular physiological, and thus 
presumably behavioral, effects constitutes one of the more.
 
5.2 Drugs that improve consolidation:
17 
This represents a logical alternative (or complementary) 
approach to improved encoding as a route for developing 
memory-enhancing drugs. Most efforts at promoting 
consolidation deal with the late, protein 
synthesis−dependent phase rather than the adhesion phase 
that develops too quickly to be a consequence of gene 
activation. The CREB family of transcription factors has 
received particular attention in this regard. CREB is 
phosphorylated and activated by the cyclic AMP-
dependent protein kinase and then binds to the cyclic AMP 
response the maintenance of the later stages of LTP. As 
expected from these physiological results, several studies 
have documented a role for CREB in long-term memory in 
Drosophila and mice. Other behavioral work implicates 
CREB in late-stage consolidation (not early stage), and 
shows that enhancing CREB functioning does indeed 
enhance the stable encoding of long-term memory, which 
is of crucial importance for drug development. 
Multiple efforts are now underway to develop drugs that 
facilitate CREB's contributions to long-term memory. 
Under some conditions, inhibitors of the phosphodiesterase 
isozyme PDE-IV, which is responsible for hydrolysis of 
cAMP, increase CREB phosphorylation, CREB binding to 
DNA, and memory scores in rats. Although the clinical use 
of current PDE IV inhibitors is restricted by unacceptable 
side effects, more potent, and perhaps selective, 
compounds are under development. Given the ubiquitous 
distribution of CREB, target selectivity (brain/forebrain) 
will be a critical requirement for drugs acting upon it to 
produce cognitive effects. At least two biotechnology 
companies (Memory Pharmaceuticals, Helicon) are 
pursuing CREB-based strategies. 
5.3 Applications:
 18
 
An FDA advisory panel recently decided that Mild 
Cognitive Impairment (MCI) is an acceptable category for 
clinical treatment. Persons with MCI have memory 
impairments relative to their age and education, but have 
significant preservation of everyday activities. Several 
studies have shown that subjects diagnosed as having MCI 
progress to Alzheimer's disease at a much higher rate (
10−15% per year) than age-matched controls. MCI is 
targeted along with Alzheimer's by most memory drug 
programs. These are enormous markets, involving perhaps 
as many as 10 million people in the US alone. Application 
beyond these well-characterized disorders depends on 
unresolved public policy issues. A substantial literature 
shows that deterioration in memory functioning is part of 
brain aging in mammals, including humans. Assuming the 
new mechanism-based memory drugs have minimal side 
effects, then the question could arise as to whether they are 
appropriate for treating conditions that, although 
disturbing, are part of the normal course of life. The 
answer to this question will determine the size of the 
market for memory drugs. 
Finally, the new pharmacology could be used to produce 
chronic improvements in MCI and early-stage Alzheimer's 
by inducing increased neurotrophic support. Regional 
changes in neuronal activity and trophic support are widely 
cited as potential causes for the neuronal atrophy found in 
the aged brain. Glutamatergic transmission regulates 
neurotrophin expression, raising the possibility that 
positive modulators of glutamate receptors will increase 
trophic factor levels and thereby offset age-related 
declines. These positive modulators increase transcription 
of brain-derived neurotrophic factor (BDNF) in cortex and 
hippocampus of adult rodents. Whether comparable effects 
are obtained in aged animals, and whether the increases are 
associated with reduced cortical atrophy, remains to be 
seen. 
6. HERBAL MEMORY ENHANCER DRUGS: 
GINSENG 
Synonyms:ninjin, pannag, panax 
Biological source: Ginseng is the dried root of various 
species of panax, like p.ginseng (Korean ginseng), p. 
japonica (Japanese ginseng), family- araliaceae. 
Mechanism of action:  depression and depressed mood 
negativity affect conginitive performance. It enhance 
memory by acting as anti anxiety and antistress like.
26 
Chemical constituents:  it contains a mixture of several 
saponin glycosides, belonging to triterpenoid group. They 
are grouped as follows: 
19 
(1.) Ginsenoside; 
(2.) Panaxosides; and 
(3.) Chikusetsusaponin 
Ginsenosides contain aglycone dammarol while 
panaxosides have oleanolic acid as aglycone. 
BRAHMI 
Synonym: Mandukparni. 
Biological source: It is the herb of Centella asiatica, 
belonging to family umbelliferae (apiaceae).
19 
Kapoor et al                                      Journal of Drug Delivery & Therapeutics; 2013, 3(5), 163-171    169 
© 2011, JDDT. All Rights Reserved                                                       ISSN: 2250-1177                                                      CODEN (USA): JDDTAO 
Mechanism of action: it enhances memory by improving 
protein synthesis in brain cells and repairs new dendritic 
growth. It also elevates curiosity.
 
Chemical constituents: it mainly contains saponins in the 
form of - amyrin derivatives called asiaticoside and 
madecassoside. They yield Asiatic acid and madecassic 
acid (triterpene acid) on hydrolysis respectively. 
 
Asiaticoside Hydrolysis Asiatic acid +2 Glucose+Rhamnose 
 
Madecassoside           Hydrolysis         Madecassic acid+2 Glucose+Rhamnose 
 
SHANKHPUSHPI 
Synonyms: shankhvel, shankhin 
Biological source:  this consists of the aerial parts of the 
plant known as Canscora decussata, family gentianaceas.
19 
 
Mechanism of action:  it is used as a brain tonic; it acts as 
a psycostimulant and tranquiliser. Psycostimulant reinforce 
behavioral activity. 
Chemical constituents:  Drug is found to contain bitter 
substance and an oleo-resin. Tow crystalline compounds 
have been isolated from the aqueous and alcoholic extracts 
of the plant. Shankhpushpi is found to contain triterpenes, 
alkaloids and xanthones.
25 
AMLA 
Synonyms: Emblica, Indian goose berry. 
Biological source: It consists of dried, as well as fresh 
fruit of plant Emblica officinalis belonging to family- 
Euphorbiaceae.
19 
Mechanism of action: The main constituents of plant is 
VIT.C which is membrane stabilizer, involved in collagen 
synthesis, strengthen neurons makin them less susceptible 
to damage. It is also a co-factor in the brain production of 
dopamine.3,25
 
Chemical constituents: It is a natural rich source of 
VIT.C. Fruit also contain fat, phyllembin and tanin  
GINGKO 
Synonym: Maiden hair tree, Kew tree 
Biological source:  the dried leaves of Gingko biloba, 
family Gingkoaceae 
Mechanism of Action:  it improve cerebral circulation, it 
works by increasing blood flow throughout the body, so 
increase the efficiency of brain.4
 
Chemical constituents:  Medicinally active ingredients of 
Gingko leaf are flavanoid glycoside, and ginkolide.
19
 
HYPERICUM 
Synonym: St. John’s Wort, Goat weed 
Biological source: It consists of dried aerial parts of the 
plant known as Hypericum perforatum, family 
hypericaceae. 
Mechanism of action:It works by boosting level of 
serotonin neurotransmitter, it also act as cognitive 
enhancer. 
Chemical constituents: Hypericum 
naphthoianthrones(anthraquinone derivative) hypericin and 
pseudo hypericin, hyperocide and flavonoids. 
Hypericins(0.06-0.75%) include hypericin red fluoeoscent 
pigment, pseudohypericin and hyperforin.
25
 
VINPOCETINE 
Trade name: Intelectol (Memory Secret, Inc.)
24 
 
Vinpocetine 
Mechanism of action:
 
Several mechanisms have been proposed for the possible 
actions of vinpocetine. Vinpocetine has been reported to 
have calcium-channel blocking activity, as well as voltage-
gated sodium channel blocking activity. It has also been 
reported to inhibit the acetylcholine release evoked by 
excitatory amino acids and to protect neurons against 
excitotoxicity. In addition, vinpocetine has been shown to 
inhibit a cyclic GMP phosphodiesterase, and it is 
speculated that this inhibition enhances cyclic GMP levels 
in the vascular smooth muscle, leading to reduced 
resistance of cerebral vessels and increase of cerebral flow. 
In some studies, vinpocetine has demonstrated antioxidant 
activity equivalent to that of vitamin E. 
LEMON BALM 
Synonyms:Balm. 
Biological source:It is obtained from the leaves of Melissa 
officinalis belonging to family- Lamiaceae. 
Chemical constituents: It contains eugenol, tannin, 
terpenes (eg. Citronellal and caryophyllene.) 
21  
 
Mechanism of action:  Depression and depressed mood 
negativity affect conginitive and mental performance. This 
herb act as a anti depressant so it improve the mental 
performance.
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HUPEZINE-A 
Scientific Name: Huperzine-A 
Huperzine A and huperzine B are two of the chemicals that 
have been separated from Chinese club moss. Huperzine B 
is also an acetylcholinesterase inhibitor, but because its 
effects are much weaker than those of huperzine A, most 
research has focused on huperzine A. Synthetic forms of 
huperzine A have been made 
in chemical laboratories and they appear to be as effective 
as natural huperzine A in studies. Huperzine A has also 
been combined or ―hybridized‖ with the prescription drug 
tacrine (Cognex), an acetylcholinesterase inhibitor 
approved by the U.S. Food and Drug Administration for 
treating Alzheimer’s disease.  
The resulting ―huprine‖ combination seems to be more 
effective at limiting acetylcholinesterase activity than 
either agent alone. Much more study needs to be done on 
the possible effects of huperzine A, huperzine B, huprine, 
and other chemicals derived from Chinese club moss.  
ASHWAGANDHA 
Synonyms:Withania root, Asgandh, Winter cherry. 
Biological source: It consists of dried roots and stem bases 
of Withania somnifera belonging to family Solonaceae.
19 
Geographical source: The plant grows wildly in all parts 
and subtropical india’. 
Mechanism of action: Depression and depressed mood 
negativity affect conginitive performance and memory 
also. Ashwagandha remove these problems means it 
reduce stress and anxiety condition and improve 
intelligence and mental performance.
24 
Chemical constituents: The main constituents of 
ashwagandha are alkaloids and steroidal lactone. Among 
various alkaloids, withanine is the main constituents. The 
leaves contain steroidal lactones, which are commonly 
called as ―withanolides‖. Withanolides have c-28 steroidal 
nucleus with c-9 side chain, having 6- membered lactone 
ring. The various withanolides are withaferin and 
withaferine-A. 
TEA 
Synonyms:Camellia thea 
Biological source: IT contains the prepared leaves and 
leaf buds of Thea sinensis 
Belonging to family Theaceae.19
 
Mechanism of action: It improves concentration and idea 
production. It contains caffeine, theanine and theophylline 
which act as a C.N.S. stimulant and also reduce stress and 
anxiety condition. 
Chemical constituents: Tea leaves are considered as arich 
source of caffeine (1-3%). It also contain theanine and 
theophylline.19
 
7. PROPOSED NATURAL TREATMENTS: 
A single study suggests that the supplement NADH might 
help improve temporary mental impairment caused by jet 
lag. 
Evidence conflicts on whether multivitamin/multimineral 
tablets may improve cognitive function in people of 
various age groups. 
 Note: Serious allegations of fraud have been raised 
regarding the work of one of the scientists involved in this 
research. 
Isoflavones in soy or red clover have inconsistently shown 
beneficial effects on mental function in women. 
Huperzine A is a potent chemical derived from a particular 
type of club moss (Huperzia serrata). This substance is 
really more a drug than an herb, but it is sold over the 
counter as a dietary supplement for memory loss and 
mental impairment. Some evidence indicates that it may be 
helpful for Alzheimer’s disease and related conditions; 
very weak evidence suggests benefit for healthy people. 
Much the same can also be said about the substance 
vinpocetine. 
Other treatments proposed for enhancing mental function 
in healthy people and having at least slight supporting 
evidence from preliminary double-blind trials include 
creatine (particularly after sleep deprivation), sage, and 
vitamin B1. 
Mild vitamin B deficiency may impair mental function. 
Because such deficiency is relatively common in the 
elderly, it has been suggested that vitamin B12 supplements 
may be appropriate in this age group. However, in the two 
studies that tried it, no benefits were seen. 3 
Seniors are also commonly deficient in vitamin B6, but a 
review of the literature failed to find meaningful evidence 
that B6 offers any benefits. 
3 
Preliminary double-blind trials suggest that the amino acid 
tyrosine may improve memory and mental function under 
conditions of sleep deprivation or other forms of stress. 
Other double-blind trials suggest that the herb Rhodiola 
rosacea may offer a similar benefit. 
 
Whey protein contains alpha-lactalbumin, a protein that in 
turn contains high levels of the amino acid tryptophan. 
Tryptophan is the body’s precursor for serotonin, and is 
thought to affect mental function. In a small double-blind 
study, use of alpha-lactalbumin in the evening improved 
morning alertness perhaps by enhancing sleep quality. 
Another small double-blind study found weak evidence 
that alpha-lactalbumin improved mental function in people 
sensitive to stress. A third study failed to find that alpha-
lactalbumin significantly improved memory in women 
experiencing premenstrual symptoms.  
Herbs that contain caffeine would be expected to enhance 
mental function in health people, at least temporarily. 
These include green tea, black tea, mate and guarana.  
Some reports suggested that declining levels of the 
hormone DHEA cause impaired mental function in the 
elderly. On this basis, DHEA has been promoted as a 
brain-boosting supplement. However, large studies have 
failed to find any correlation between DHEA levels and 
mental function, and there is no direct evidence that 
DHEA supplements provide any benefit in seniors. One 
study did find potential benefits in younger people. 
Other herbs and supplements proposed for enhancing 
memory and mental function, but that lack meaningful 
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supporting evidence, includes rosemary, saffron, Muira 
puama, Sageand lobelia.  
One study failed to find folate helpful for enhancing 
mental function in seniors; another failed to find benefit 
with folate plus vitamin B12. 
8. CONCLUSION: 
From this cram, it is comprehensible that the herbals 
engage in recreationadjacent to poor memory. An 
assortment of herbal plants and plants extracts has 
considerable memory improving activity in animal models. 
They have anti-acetylcholinesterase property and may be 
valuable as a nootropic agent in delaying the onset and 
reducing the severity of Alzheimer’s disease when 
compared with that of reference drugs. The memory 
improving activity is probably due to the presence of 
flavonoids in almost all these plants. A variety of botanical 
products have been reported to possess memory improving 
activity; in conclusion, it should be noted that substances 
such as flavonoids, and tannins that own memory 
improving activity are of particular therapeutic importance. 
The consequences of this study indicate that extracts of 
leaves and plants extracts of some medicinal plant have 
good impending for use in poor memory. It has been 
ascribed with a overabundance of physiological effects that 
could potentially benefit cognitive performance or mood. 
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